Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus

Abstract : Despite the success of targeted therapies in managing immune-mediated inflamma-tory diseases (IMIDs) such as RA, IBDs, MS and psoriasis, unmet needs for such approach in SLE are widely recognized. In the past 2 years, exciting insights supporting previous lines of evidence on the role of the IL-23/IL-17 axis in SLE have emerged. This is of particular importance as IL-17 blockers have now moved successfully into the clinical space, as illustrated in psoriasis and ankylosing spondylitis. However, recent fundamental studies also highlighted unexpected aspects of IL-17/Th17 biology whose comprehension may prevent disappointing results of IL-17 targeting such as those obtained in Crohn's disease. Therefore, establishing a current picture of the IL-17 pre-clinical situation in SLE is timely in order to plan future proof-of-concept studies in human.
Keywords : IL-17 Th17 SLE
Document type :
Journal articles
Complete list of metadatas

Cited literature [143 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02164493
Contributor : Ana Paula Dutra Azevedo <>
Submitted on : Tuesday, June 25, 2019 - 10:23:39 AM
Last modification on : Saturday, June 29, 2019 - 1:31:49 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Jérôme Martin, Dominique Baeten, Régis Josien. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clinical Immunology, Elsevier, 2014, 154 (1), pp.1-12. ⟨10.1016/j.clim.2014.05.004⟩. ⟨inserm-02164493⟩

Share

Metrics

Record views

27